| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/24/2023 | 175.86% | HC Wainwright & Co. | → $4 | Reiterates | Buy → Buy |
| 08/14/2023 | 175.86% | HC Wainwright & Co. | $5 → $4 | Maintains | Buy |
| 07/14/2023 | 244.83% | HC Wainwright & Co. | → $5 | Reiterates | Buy → Buy |
| 05/12/2023 | 244.83% | HC Wainwright & Co. | → $5 | Reiterates | Buy → Buy |
| 05/08/2023 | 244.83% | HC Wainwright & Co. | → $5 | Reiterates | → Buy |
| 03/30/2023 | 244.83% | HC Wainwright & Co. | → $5 | Reiterates | → Buy |
| 03/23/2023 | 244.83% | HC Wainwright & Co. | → $5 | Reiterates | → Buy |
| 02/10/2023 | 244.83% | HC Wainwright & Co. | → $5 | Reiterates | → Buy |
| 12/15/2022 | 244.83% | HC Wainwright & Co. | $8 → $5 | Maintains | Buy |
| 08/08/2022 | 451.72% | HC Wainwright & Co. | $4 → $8 | Maintains | Buy |
| 05/16/2022 | 175.86% | HC Wainwright & Co. | $6 → $4 | Maintains | Buy |
| 02/11/2022 | 313.79% | HC Wainwright & Co. | $8 → $6 | Maintains | Buy |
| 08/13/2021 | 658.62% | HC Wainwright & Co. | $13 → $11 | Maintains | Buy |
| 04/22/2021 | 796.55% | HC Wainwright & Co. | $14 → $13 | Maintains | Buy |
| 02/12/2021 | 1555.17% | Roth Capital | → $24 | Initiates Coverage On | → Buy |
| 01/14/2021 | 865.52% | HC Wainwright & Co. | $18 → $14 | Maintains | Buy |
| 01/11/2021 | 1141.38% | HC Wainwright & Co. | $12 → $18 | Maintains | Buy |
| 11/30/2020 | 1279.31% | HC Wainwright & Co. | $22 → $20 | Maintains | Buy |
| 07/20/2020 | 1417.24% | HC Wainwright & Co. | $18 → $22 | Maintains | Buy |
| 07/02/2020 | 1141.38% | HC Wainwright & Co. | → $18 | Initiates Coverage On | → Buy |
| 11/22/2019 | 451.72% | Maxim Group | → $8 | Upgrades | Hold → Buy |
What is the target price for Applied DNA Sciences (APDN)?
The latest price target for Applied DNA Sciences (NASDAQ: APDN) was reported by HC Wainwright & Co. on August 24, 2023. The analyst firm set a price target for $4.00 expecting APDN to rise to within 12 months (a possible 175.86% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Applied DNA Sciences (APDN)?
The latest analyst rating for Applied DNA Sciences (NASDAQ: APDN) was provided by HC Wainwright & Co., and Applied DNA Sciences reiterated their buy rating.
When is the next analyst rating going to be posted or updated for Applied DNA Sciences (APDN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Applied DNA Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Applied DNA Sciences was filed on August 24, 2023 so you should expect the next rating to be made available sometime around August 24, 2024.
Is the Analyst Rating Applied DNA Sciences (APDN) correct?
While ratings are subjective and will change, the latest Applied DNA Sciences (APDN) rating was a reiterated with a price target of $0.00 to $4.00. The current price Applied DNA Sciences (APDN) is trading at is $1.45, which is within the analyst's predicted range.